Pharmaceutical Composition for Gynecological Diseases in Specialized Environments

Publication ID: 24-11857586_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Pharmaceutical Composition for Gynecological Diseases in Specialized Environments,” Published Technical Disclosure No. 24-11857586_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857586_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,586.

Summary of the Inventive Concept

A novel pharmaceutical composition and system for preventing or treating gynecological diseases in extreme weather conditions, high-security environments, disaster relief scenarios, and areas with limited access to medical facilities, utilizing Sarcodon aspratus extracts as active ingredients.

Background and Problem Solved

The original patent disclosed a pharmaceutical composition for preventing or treating gynecological diseases using Sarcodon aspratus extracts. However, this composition may not be suitable for use in extreme weather conditions, high-security environments, disaster relief scenarios, or areas with limited access to medical facilities. The present inventive concept addresses these limitations by adapting the composition and system for these specialized environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a portable pharmaceutical composition dispenser adapted to dispense a pharmaceutical composition containing Sarcodon aspratus extracts as active ingredients, designed to operate in temperatures ranging from -20°C to 40°C. Additionally, the composition can be formulated to be undetectable by security screening devices for use in high-security environments. In disaster relief scenarios, the kit comprises a pharmaceutical composition, a water purification system, and a portable heating device. The composition can also be formulated to have a prolonged shelf life and packaged in a compact, lightweight container for use in areas with limited access to medical facilities. Furthermore, a system for remote monitoring and treatment of gynecological diseases can be implemented, comprising a wearable device, a communication module, and a pharmaceutical composition dispenser, designed to operate in areas with limited internet connectivity.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of the original pharmaceutical composition for use in specialized environments, such as extreme weather conditions, high-security environments, disaster relief scenarios, and areas with limited access to medical facilities. The inventive step is the integration of the composition with novel dispensing systems, formulations, and packaging designs that enable its effective use in these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include variations in the dispenser design, such as solar-powered or hand-cranked dispensers, or the use of different active ingredients in combination with Sarcodon aspratus extracts. Additionally, the system for remote monitoring and treatment could be implemented using different communication protocols or wearable devices.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of disaster relief, high-security environments, and remote healthcare. The target market includes government agencies, non-governmental organizations, and private companies operating in these specialized environments.

CPC Classifications

SectionClassGroup
A A61 A61K36/07
A A61 A61K9/0056
A A61 A61P15/08
A A61 A61K2236/333

Original Patent Information

Patent NumberUS 11,857,586
TitlePharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient